Fasoracetam 30mg (900mg)
Fasoracetam is a nootropic used to enhance cognitive function in animals, currently, it is being studied as a possible treatment of ADHD and anxiety.
It was first developed in the early 1990s by the Japanese pharmaceutical company Nippon Shinyaku they were looking to treat dementia.
After spending $200 million developing it Fasoracetam failed to make it past phase 3 clinical trials.
In 2013 NeuroFix bought all the clinical data from Nippon Shinyaku and was then sold to Aevi Genomic Medicine.
They restarted the clinical trials in 2016 in ADHD, autism, or anxiety, in teenagers who have mutant glutamate receptor genes, currently, it is in phase 2 trials.
Mechanism of ACTION
Interestingly it also increases choline, a much-needed nutrient used in the creation and synthesis of acetylcholine that is distributed throughout the brain.
It will lead to improving the number of receptors directly inhibiting GABA (gamma-aminobutyric acid).
Fasoracetam antagonizes glutamate receptors the main excitatory neurotransmitter.
Dosage In a clinical trial (double-blind randomized controlled trial) involving ADHD patients, fasoracetam was used at doses of 100, 200, and 400 mg two times a day orally.
Anecdotally, users report effective doses between 100 and 800 mg daily. The supplement containing choline would prove extra benefit due to the increased need for acetylcholine.
Like all racetams, it increases choline uptake in the brain.
An increase in Gaba receptors along with activation of glutamate makes it a stand out in the nootropic category.
These products are certified reference material and sold for research purposes only
Alex wimWednesday, February 27, 2019, 15:15Definitively my go to to chill down around the afternoon, the effect is really amazing good to stack with colouracetam.
FOR RESEARCH USE ONLYNOT FOR HUMAN OR ANIMAL CONSUMPTION
Nootropic60 X 30mg